Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.
Cancer Res Treat
; 56(1): 134-142, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37591782
Full text:
1
Database:
MEDLINE
Main subject:
Tamoxifen
/
Breast Neoplasms
Language:
En
Journal:
Cancer Res Treat
Year:
2024
Type:
Article
Affiliation country:
China